Back

Communications Biology

36 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Multi-Omics characterization of biological pathways linking healthy dietary patterns to cardiometabolic disease risk across diverse populations
2026-02-26 epidemiology 10.64898/2026.02.23.26346874
#1 (3.7%)
Show abstract

Background and ObjectivesRecent large-scale studies have consistently linked healthy dietary patterns to improved cardiometabolic health; however, the underlying biological pathways remain largely unclear, especially in non-European populations. In this study, we leverage data from four population-based cohorts (UK Biobank, NEO study, GNHS, and 10K) to investigate both common and cohort-specific biological pathways linking healthy dietary patterns to cardiometabolic disease through multi-omics p...

2
Rare Coding Variant Associations With Primary Open-Angle Glaucoma In African Ancestry:A Multi-Cohort Exome-Wide Meta Analysis
2026-02-27 ophthalmology 10.64898/2026.02.25.26347141
#1 (3.5%)
Show abstract

Primary open-angle glaucoma (POAG) disproportionately affects individuals of African ancestry, yet rare coding variation in this population remains understudied. To address this gap, we performed a multi-cohort exome-wide meta-analysis across POAAGG, PMBB, All of Us, and UK Biobank, including 4,815 POAG cases and 22,922 controls of genetically inferred African ancestry. Although no gene reached exome-wide significance, we identified several suggestive gene-level associations driven by rare varia...

3
A large deletion spanning multiple enhancers near PITX2 increases primary open-angle glaucoma risk
2026-03-02 ophthalmology 10.64898/2026.02.26.25342774
Top 0.1% (3.1%)
Show abstract

ImportanceGenome-wide association studies have identified hundreds of common single nucleotide polymorphisms (SNPs) and small insertions/deletions (indels) associated with primary open-angle glaucoma (POAG) risk, though these variants have modest effect sizes and individually may have minor contributions to disease development. As whole-genome sequencing data is becoming more readily available, structural variants and other complex genomic features can be interrogated for contribution to disease...

4
Bridging the Genomic Equity Gap with Context-Enhanced Risk Stratification in American Indians: the Strong Heart Study
2026-02-11 genetic and genomic medicine 10.64898/2026.02.08.26345859
Top 0.2% (2.6%)
Show abstract

Polygenic scores (PGS) show promise for disease risk stratification but suffer from limited portability across populations. American Indians face a disproportionate burden of cardiovascular disease yet remain significantly underrepresented in genomic research, limiting equitable access to precision medicine. Here, we evaluate whether integrating specific lifestyle and clinical context variables with PGS enhances risk prediction for cardiometabolic traits in 424,622 European from UK Biobank (UKB)...

5
Biomarker Identification in Pancreatic Cancer Through Concordant Differential Expression and Interpretable Machine Learning Analyses
2026-02-16 oncology 10.64898/2026.02.13.26346263
Top 0.2% (2.1%)
Show abstract

BackgroundPancreatic ductal adenocarcinoma is one of the most aggressive and lethal malignancies of the gastrointestinal tract. The poor prognosis is largely attributed to late-stage diagnosis, pronounced tumor heterogeneity, and limited therapeutic efficacy. These challenges underscore the urgent need for the identification of robust molecular biomarkers and novel therapeutic targets. MethodsGene expression data from a total of 146 pancreatic tissue samples, comprising 72 normal and 74 tumor s...

6
A spatial multi-omic portrait of survival outcome for clear cell renal cell carcinoma
2026-03-04 oncology 10.64898/2026.03.02.26347390
Top 0.3% (2.0%)
Show abstract

Clear cell renal cell carcinoma (ccRCC) is the leading cause of kidney cancer-related death, but how the tumor microenvironment shapes patient survival is not completely understood. Here, we describe the characterization of ccRCC tumor ecosystems from 498 patients using imaging mass cytometry with a focus on tumor, myeloid, and T cell landscapes. Data from more than 3 million single cells is analyzed using machine-learning to identify key ecosystem features that outperform basic clinical data fo...

7
Absolutely quantitated protein levels to reveal an ER/PR framework governing the full spectrum of breast cancer
2026-03-03 oncology 10.64898/2026.03.02.26347441
Top 0.3% (2.0%)
Show abstract

Cancer heterogeneity is traditionally attributed to multiple parallel signaling pathways. This belief is challenged here by proposing the ER/PR axis as the dominant pathway underlying the full spectrum of breast cancer. Absolutely quantitated ER, PR, Her2 and Ki67 protein levels were accumulated over 8 years from 1652 specimens collected non-selectively and measured with Quantitative Dot Blot (QDB) method over time. Cox analysis showed ER and Ki67 as independent adverse prognostic factors while ...

8
Semaglutide alters the human embryo-endometrium interface
2026-03-07 obstetrics and gynecology 10.64898/2026.03.03.26347354
Top 0.3% (2.0%)
Show abstract

The use of semaglutide (SE), a glucagon-like peptide-1 receptor agonist (GLP-1RA) with glucose-lowering and weight-loss effects, has risen rapidly, particularly among women of reproductive age. While preclinical studies suggest benefits for ovarian function via the hypothalamic-pituitary-ovarian axis, its impact on the endometrial-embryo interface remains unclear. Here, we show that GLP-1R is dynamically expressed in fertile human endometrium, restricted to epithelial cells and markedly upregula...

9
High-dimensional CyTOF profiling reveals distinct maternal and fetal immune landscapes in gestational diabetes mellitus
2026-02-18 allergy and immunology 10.64898/2026.02.17.26346459
Top 0.4% (1.9%)
Show abstract

AimsGestational diabetes mellitus (GDM) is the most common pregnancy-related medical complication. GDM is linked to aberrant immune responses in both mothers and offsprings, specifically, the subsequent development of inflammatory diseases. Whereas prior research has focused on specific immune cell subsets, a comprehensive overview of the impacts of GDM on maternal and fetal immune landscape is lacking. Here, we aim to comprehensively decipher how GDM modulates various immune cell populations in...

10
Acellular Adipose Tissue promotes anti-fibrotic remodeling in Phase II Study
Top 0.4% (1.9%)
Show abstract

Acellular Adipose Tissue (AAT) is an off-the-shelf, cadaveric adipose-derived ECM-based biomaterial for soft tissue reconstruction. AAT has been validated preclinically to promote angiogenesis and adipogenesis and demonstrated safety, biocompatibility, and tolerability in a Phase I study. In this study we report the findings for the first ten patients in the Phase II study for permanent reconstruction of modest soft tissue defects. AAT promoted macrophages, CD3+ T cells, and CD34+ progenitor act...

11
AI Generated Stromal Biomarkers for DCIS Reccurence Prediction
2026-02-17 oncology 10.64898/2026.02.13.26346278
Top 0.5% (1.9%)
Show abstract

BackgroundAlthough DCIS has a relatively low recurrence rate, many patients still receive adjuvant radiotherapy or endocrine therapy, raising concerns about overtreatment. Reliable biomarkers are therefore needed to predict an individual patients risk and guide treatment decisions. Recent studies suggest that the composition of the tumour-associated stroma (TAS) affects progression and outcome, highlighting TAS-derived biomarkers as promising candidates for further investigation. MethodsWe trai...

12
Learning lifetime disease liability reveals and removes genetic confounding in electronic health records
2026-02-22 genetic and genomic medicine 10.64898/2026.02.15.26346336
Top 0.5% (1.9%)
Show abstract

Electronic health records (EHRs) have become the cornerstone of population-scale genetic studies1, but factors including patterns of healthcare use shape which and how diagnoses are recorded, leading to confounding effects in genetic associations with EHR codes2. In this study we propose EDGAR, a deep learning framework that recovers lifetime disease liability from EHR by aligning diagnostic codes with clinically validated measures and disease labels in a set of individuals prioritized through a...

13
Gene-by-Sleep Duration Interaction for Glycemic Traits in over 480,000 Individuals
2026-03-03 genetic and genomic medicine 10.64898/2026.03.02.26346498
Top 0.6% (1.8%)
Show abstract

Both short and long sleep duration have been associated with poor glycemic control and an increased risk of developing type 2 diabetes mellitus. Although sleep duration may differentially modify the effects of genetic risk factors for type 2 diabetes, this has not been systematically investigated. In the present study, we conducted genome-wide gene by sleep duration meta-analyses, separately assessing interactions of short and long sleep, for fasting glucose, fasting insulin, and hemoglobin A1c ...

14
Leisure-time physical activity on lifelong trajectories of body mass index and obesity risk throughout life: multivariable regression and Mendelian randomization analyses using real-world data from the CORDELIA-Catalunya Study
2026-02-25 epidemiology 10.64898/2026.02.23.26346892
Top 0.6% (1.8%)
Show abstract

BackgroundEvidence on how leisure-time physical activity (LTPA) improves lifetime body mass index (BMI) remains fragmented and prone to confounding. MethodsWe pooled 14,993 adults (30-90 y; 52.7% women; cohorts: REGICOR-ACRISC, ILERVAS, ARTPER) with baseline estimated LTPA (moderate-to-vigorous LTPA [MVLTPA] in REGICOR-ACRISC), genotype, and repeated BMI values from electronic health records (1990-2024, 36,157 measures). LTPA was categorized into cohort-specific quartiles; MVLTPA in 0, <100, <2...

15
Prediction of Buruli ulcer treatment shortening with novel beta-lactam-containing antimicrobial combinations
2026-03-02 infectious diseases 10.64898/2026.02.28.26347324
Top 0.7% (1.8%)
Show abstract

IntroductionBuruli ulcer (BU) is a neglected tropical disease primarily affecting skin and sometimes bone. Standard therapy consists of rifampicin (RIF, once daily) plus clarithromycin (CLA, twice daily) over 8 weeks. Adding amoxicillin-clavulanate (AMX/CLV) may shorten treatment, but predicting treatment success before clinical trial implementation is challenging. AimsTo assess the probability of bacterial eradication following treatment with novel investigational BU regimens over different in...

16
Melanocyte loss dominates the vitiligo transcriptome: a rank-based meta-analysis of six independent studies
2026-02-09 dermatology 10.64898/2026.02.07.26345817
Top 0.8% (1.6%)
Show abstract

Vitiligo is an autoimmune disorder characterized by melanocyte destruction. We performed a rank-based meta-analysis of six independent transcriptomic studies (115 samples) spanning microarray, bulk and single-cell RNA-seq platforms to identify consensus signatures of lesional skin. Robust Rank Aggregation identified 114 differentially expressed genes (FDR < 0.05) with striking asymmetry: 108 downregulated versus 6 upregulated. Downregulated genes were dominated by melanocyte markers (MLANA, TYR...

17
Short tandem repeats significantly contribute to the genetic architecture of metabolic and sensory age-related hearing loss phenotypes
2026-02-18 genetic and genomic medicine 10.64898/2026.02.17.26346449
Top 0.9% (1.6%)
Show abstract

Age-related hearing loss (ARHL) is a progressive, bilateral decline in hearing ability that affects one in four individuals over 60 years of age worldwide. While previous genome-wide association studies (GWAS) have identified distinct single-nucleotide variants (SNVs) associated with metabolic and sensory ARHL phenotypes, the contribution of short tandem repeats (STRs) - a neglected yet important class of genetic variants - remains poorly understood. To address this gap, TRTools was used to impu...

18
Substance P, mast cells and basophils are involved in acute chest syndrome in sickle cell disease
2026-03-03 hematology 10.64898/2026.03.02.26347450
Top 0.9% (1.5%)
Show abstract

A role for substance P in promoting neurogenic inflammation and pain has been described in sickle cell disease (SCD). However its origin and contribution to SCD pathophysiology remain unclear. We measured substance P level in plasma from 225 patients with SCD and observed the highest concentrations during acute chest syndrome (ACS). Therefore, we tested the hypothesis that substance P may induce ACS. In transgenic sickle mice, unlike control mice, intravenous injection of substance P caused leth...

19
Comparing an AI test to a 21-gene assay for premenopausal node-positive HR+/HER2- breast cancer
2026-02-09 oncology 10.64898/2026.02.06.26345771
Top 1.0% (1.5%)
Show abstract

Recurrence scores based on a 21-gene assay are clinically useful for predicting prognosis and chemotherapy benefit in postmenopausal node-positive breast cancer patients, but its performance in premenopausal patients is inconsistent. Here, we evaluated Ataraxis Breast RISK (ATX), an AI test that predicts recurrence risk, and compared it with the genomic assay. ATX identified high risk patients misclassified as low risk by the genomic assay and therefore may refine selection of patients for adjuv...

20
Personal-MetaboHealth, an actionable health check in middle age, is improved by an effective lifestyle intervention in those at risk
2026-02-17 public and global health 10.64898/2026.02.15.26346369
Top 1% (1.5%)
Show abstract

The biomarker MetaboHealth represents a novel indicator of overall health in middle age and may potentially be suitable as actionable health check in prevention strategies. MetaboHealth is a blood-based metabolomic composite score that predicts a wide range of age-related conditions and mortality in large European cohorts. Here, we investigated whether MetaboHealth can be personalised and limited to clinically validated metabolomic markers. Next, we assessed whether the updated MetaboHealth scor...